May 19, 2022
RegMed Investors’ (RMi) closing bell: sector was kicked, but not put on its butt
May 18, 2022
RegMed Investors’ (RMi) closing bell: Tuesday was a short-lived rally as sector equities plummet Wednesday
May 17, 2022
RegMed Investors’ (RMi) closing bell: enjoying the cell and gene therapy sector high and I didn’t even inhale
May 13, 2022
RegMed Investors’ (RMi) closing bell: session two (2) in a row of three (3) positive closes in the week
May 12, 2022
RegMed Investors’ (RMi) closing bell: miracle moves, the oversold ascended to the upside
May 11, 2022
RegMed Investors’ (RMi) closing bell: sector pricing was taken to the woodshed and whupped
May 10, 2022
RegMed Investors’ (RMi) closing bell: a bounce to the upside
May 4, 2022
RegMed Investors’ (RMi) closing bell: a wild and volatile sector ride that ended to the upside
May 2, 2022
RegMed Investors’ (RMi) closing bell: the oversold were noticed but, for how long?
April 29, 2022
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector dives, TGIF and April is over
April 28, 2022
RegMed Investors’ (RMi) closing bell: gravity was overcome for the cell and gene therapy sector
April 27, 2022
RegMed Investors’ (RMi) closing bell: wherefore art thou sentiment
April 25, 2022
RegMed Investors’ (RMi) closing bell: big share price reversal helps resets the cell and gene therapy sector’s oversold
April 22, 2022
RegMed Investors’ (RMi) closing bell: what happened today, another sector face plant in the mud
April 21, 2022
RegMed Investors’ (RMi) closing bell: market conditions and sector sentiment are hammered
April 20, 2022
RegMed Investors’ (RMi) closing bell: low volume lethargy enables fatigued sentiment hampering some share pricings
April 19, 2022
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector’s ascension
April 18, 2022
RegMed Investors’ (RMi) closing bell: Why the slide …
April 14, 2022
RegMed Investors’ (RMi) closing bell: closing with a downslide shortened week with Friday market holiday
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2022 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.